Table 1.
Clinicopathological features of 86 patients with pT3 upper tract UC stratified by GAL1 expression.
| GAL1-Low | GAL1-High | p-Value | |
|---|---|---|---|
| (N = 51, %) | (N = 35, %) | ||
| Age (years) | 70.5 ± 10.8 | 68.0 ± 9.8 | 0.27 |
| Gender | |||
| Female | 31 (60.8) | 18 (51.4) | 0.39 |
| Male | 20 (39.2) | 17 (48.6) | |
| Smoking | |||
| Yes | 8 (15.7) | 4 (11.4) | 0.75 |
| No | 43 (84.3) | 31 (88.6) | |
| Primary site | |||
| Renal pelvis | 26 (51.0) | 26 (74.3) | 0.09 |
| Ureter | 19 (37.3) | 7 (20.1) | |
| Both | 6 (11.8) | 2 (5.7) | |
| Grade | |||
| Low | 0 (0) | 1 (2.9) | 0.41 |
| High | 51 (100) | 34 (97.1) | |
| Histopathologic variant | |||
| Presence | 20 (39.2) | 14 (40) | 0.94 |
| Absence | 31 (60.8) | 21 (60) | |
| CIS | |||
| Presence | 17 (33.3) | 13 (37.1) | 0.72 |
| Absence | 34 (66.7) | 22 (62.9) | |
| LVI | |||
| Presence | 20 (39.2) | 14 (40) | 0.94 |
| Absence | 31 (60.8) | 21 (60) | |
| Tumor necrosis | |||
| Presence | 18 (35.3) | 16 (45.7) | 0.33 |
| Absence | 33 (64.7) | 19 (54.3) | |
| Multicentricity | |||
| Yes | 12 (23.5) | 5 (14.3) | 0.29 |
| No | 39 (76.5) | 30 (85.7) | |
| Papillary feature | |||
| Presence | 31 (60.8) | 15 (42.9) | 0.10 |
| Absence | 20 (39.2) | 20 (57.1) |
Abbreviations: CIS, carcinoma in situ; LVI, lymphovascular invasion.